DTIL
Precision Biosciences IncCompany with tickers: DTIL
CIK
1357874
CUSIP
74019P207
Shares Outstanding
25,802,247
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $10,838,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $19,913,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Research & Development | $13,110,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Operating Income | $-9,075,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Net Income | $-18,441,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | $-0.75 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Diluted) | $-0.75 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |